SMG1 and osteosarcoma: 2 showed that SMG‐1 suppressed oncogenic CDK2‐driven proliferation and was a tumor suppressor in osteosarcoma. Similarly, in human papillomavirus (HPV)‐positive head and neck squamous cell carcinoma, SMG‐1 was underexpressed and exhibited tumor‐suppressive activity 3.